| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 11.129 | 29.468 | 50.837 | 41.232 | 61.413 | 59.696 | 71.769 | 87.263 |
| Total Income - EUR | - | - | 11.129 | 29.468 | 50.837 | 41.711 | 61.413 | 59.696 | 71.769 | 87.393 |
| Total Expenses - EUR | - | - | 7.974 | 21.088 | 31.700 | 23.925 | 39.475 | 44.335 | 50.247 | 64.486 |
| Gross Profit/Loss - EUR | - | - | 3.156 | 8.380 | 19.137 | 17.786 | 21.938 | 15.361 | 21.522 | 22.906 |
| Net Profit/Loss - EUR | - | - | 2.330 | 7.766 | 18.629 | 17.506 | 21.427 | 14.740 | 20.915 | 20.284 |
| Employees | - | - | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Nior Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 20.768 | 16.736 | 14.433 | 10.435 | 7.836 | 13.600 | 10.006 | 22.092 |
| Current Assets | - | - | 1.519 | 7.485 | 14.765 | 14.153 | 18.213 | 13.788 | 20.466 | 26.400 |
| Inventories | - | - | 234 | 1.965 | 236 | 577 | 717 | 1.341 | 864 | 1.231 |
| Receivables | - | - | 0 | 322 | 0 | 0 | 7.345 | 10.950 | 15.510 | 15.838 |
| Cash | - | - | 1.285 | 5.198 | 14.528 | 13.576 | 10.151 | 1.497 | 4.092 | 9.331 |
| Shareholders Funds | - | - | 2.374 | 8.806 | 18.688 | 17.854 | 21.702 | 14.792 | 21.106 | 20.365 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 19.914 | 15.414 | 10.510 | 6.733 | 4.346 | 12.596 | 9.366 | 28.127 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Nior Medical S.r.l.